RT Journal Article
SR Electronic
T1 Analysis of Clinical Recovery-Period and Recovery Rate Estimation of the First 1000 COVID-19 Patients in Singapore
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.17.20069724
DO 10.1101/2020.04.17.20069724
A1 Sreevalsan-Nair, Jaya
A1 Vangimalla, Reddy Rani
A1 Ghogale, Pritesh Rajesh
YR 2020
UL http://medrxiv.org/content/early/2020/04/24/2020.04.17.20069724.abstract
AB COVID-19 has been declared as a global pandemic by the World Health Organization (WHO) on March 11, 2020. In this paper, we investigate various aspects of the clinical recovery of the first 1000 COVID-19 patients in Singapore, spanning from January 23 to April 01, 2020. This data consists of 245 clinically recovered patients. The first part of the paper studies the descriptive statistics and the influence of demographic parameters, namely age and gender, in the clinical recovery-period of COVID-19 patients. The second part of the paper is on identifying the distribution of the length of the recovery-period for the patients. We identify a piecewise analysis of three different periods, identified based on trends of both positive confirmation and clinical recovery of COVID-19. As expected, the overall recovery rate has reduced drastically during the exponential increase of incidences. However, our in-depth analysis shows that there is a shift in the age-group of incidences to the younger population, and the recovery-period of the younger population is considerably lower. Here, we have estimated the recovery rate to be 0.125. Overall, the prognosis of COVID-19 indicates an improvement in recovery rate owing to the government-mandated practices of restricted mobility of the older population and aggressive contact tracing.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors have not received any external funding for conducting this work.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the data used for this work has been obtained from the press releases on the official website of the Ministry of Health, the Government of Singapore. https://www.moh.gov.sg/news-highlights/